Headquartered in Long Beach, CA Fiscal year ends December NASDAQ: SKIN skinhealthsystems.com
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company that delivers an integrated ecosystem of clinically proven skincare solutions for both consumers and professional providers. The company's flagship brand, Hydrafacial, is a widely requested professional skincare treatment. The portfolio also includes SkinStylus microneedling and HydraScalp with Keravive scalp treatments. The company operates a razor-and-blade business model, selling delivery systems (devices) and recurring proprietary consumables through a global omnichannel network of aesthetic providers. SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation, serving providers across the Americas, Asia Pacific, and EMEA regions. The company has been transitioning certain markets, including China, Australia, and New Zealand, to distributor partners. Updated
As we age, our bodies begin to slow down the production of various things that help us appear youthful. Collagen, elastin, and even lean muscle tissue, a process known as atrophy, all…
Thursday's top analyst upgrades and downgrades included Adobe, Amazon.com, Avantor, Chipotle Mexican Grill, Coherent, FedEx, Infosys, Micron Technology, Peloton Interactive, Petrobras, Snowflake, Tesla and Victoria's Secret.
Wednesday's top analyst upgrades and downgrades included Activision Blizzard, Alcoa, Amgen, Bank of New York Mellon, Boston Beer, Charles Schwab, Freeport-McMoRan, Kroger, Live Nation Entertainment, Mattel, Southern Company and Valero Energy.
Wednesday’s top analyst upgrades and downgrades included Alliance Data, AvalonBay, Boston Properties, Bruker, Camden Properties and CBRE.
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company that delivers an integrated ecosystem of clinically proven skincare solutions for both consumers and professional providers. The company's flagship brand, Hydrafacial, is a widely requested professional skincare treatment.
The Wall Street consensus 12-month price target for SKIN is $18.17.
